366 related articles for article (PubMed ID: 29520277)
1. Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.
Geven C; Kox M; Pickkers P
Front Immunol; 2018; 9():292. PubMed ID: 29520277
[TBL] [Abstract][Full Text] [Related]
2. Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in Sepsis.
Geven C; Bergmann A; Kox M; Pickkers P
Shock; 2018 Aug; 50(2):132-140. PubMed ID: 29324626
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin in heart failure: pathophysiology and therapeutic application.
Voors AA; Kremer D; Geven C; Ter Maaten JM; Struck J; Bergmann A; Pickkers P; Metra M; Mebazaa A; Düngen HD; Butler J
Eur J Heart Fail; 2019 Feb; 21(2):163-171. PubMed ID: 30592365
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2).
Geven C; Blet A; Kox M; Hartmann O; Scigalla P; Zimmermann J; Marx G; Laterre PF; Mebazaa A; Pickkers P
BMJ Open; 2019 Feb; 9(2):e024475. PubMed ID: 30782906
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis.
Geven C; Peters E; Schroedter M; Struck J; Bergmann A; McCook O; Radermacher P; Kox M; Pickkers P
Shock; 2018 Dec; 50(6):648-654. PubMed ID: 29324627
[TBL] [Abstract][Full Text] [Related]
6. Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis.
Deniau B; Takagi K; Asakage A; Mebazaa A
Expert Opin Investig Drugs; 2021 Feb; 30(2):95-102. PubMed ID: 33256482
[No Abstract] [Full Text] [Related]
7. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.
van Lier D; Kox M; Pickkers P
J Intern Med; 2021 Jun; 289(6):792-806. PubMed ID: 33381880
[TBL] [Abstract][Full Text] [Related]
8. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Maggio G; Cavana M; Tognoni G; Pesenti A; Gattinoni L; Masson S;
Chest; 2017 Aug; 152(2):312-320. PubMed ID: 28411114
[TBL] [Abstract][Full Text] [Related]
9. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin in Sepsis: Finally, a Friend or an Enemy?
Ajith Kumar AK
Indian J Crit Care Med; 2020 Dec; 24(12):1151-1153. PubMed ID: 33446960
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.
Geven C; van Lier D; Blet A; Peelen R; Ten Elzen B; Mebazaa A; Kox M; Pickkers P
Br J Clin Pharmacol; 2018 Sep; 84(9):2129-2141. PubMed ID: 29856470
[TBL] [Abstract][Full Text] [Related]
12. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines.
Koo DJ; Yoo P; Cioffi WG; Bland KI; Chaudry IH; Wang P
J Surg Res; 2000 Jun; 91(1):70-6. PubMed ID: 10816353
[TBL] [Abstract][Full Text] [Related]
14. Adrenomedullin surges are linked to acute episodes of the systemic capillary leak syndrome (Clarkson disease).
Xie Z; Chen WS; Yin Y; Chan EC; Terai K; Long LM; Myers TG; Dudek AZ; Druey KM
J Leukoc Biol; 2018 Apr; 103(4):749-759. PubMed ID: 29360169
[TBL] [Abstract][Full Text] [Related]
15. Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock:
van Lier D; Picod A; Marx G; Laterre PF; Hartmann O; Knothe C; Azibani F; Struck J; Santos K; Zimmerman J; Bergmann A; Mebazaa A; Pickkers P
Front Med (Lausanne); 2022; 9():1058235. PubMed ID: 36530868
[TBL] [Abstract][Full Text] [Related]
16. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin.
Wang RL; Kang FX
Chin J Traumatol; 2010 Jun; 13(3):152-7. PubMed ID: 20515592
[TBL] [Abstract][Full Text] [Related]
17. Reduction in vascular responsiveness to adrenomedullin during sepsis.
Wang P; Yoo P; Zhou M; Cioffi WG; Ba ZF; Chaudry IH
J Surg Res; 1999 Jul; 85(1):59-65. PubMed ID: 10383838
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Non-Neutralizing Humanized Monoclonal Anti-Adrenomedullin Antibody Adrecizumab on Hemodynamic and Renal Injury in a Porcine Two-Hit Model.
Thiele C; Simon TP; Szymanski J; Daniel C; Golias C; Hartmann O; Struck J; Martin L; Marx G; Schuerholz T
Shock; 2020 Dec; 54(6):810-818. PubMed ID: 32554994
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis.
Wang P; Ba ZF; Cioffi WG; Bland KI; Chaudry IH
Arch Surg; 1998 Dec; 133(12):1298-304. PubMed ID: 9865646
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin and adrenomedullin binding protein-1 protect endothelium-dependent vascular relaxation in sepsis.
Zhou M; Maitra SR; Wang P
Mol Med; 2007; 13(9-10):488-94. PubMed ID: 17932560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
